Lin-Lin Cao1, Zhaoming Chen2, Zhihong Yue1, Lin Pei1, Mei Jia1, Hui Wang1, Tingting Li2. 1. Department of Clinical Laboratory, Peking University People's Hospital, Beijing, China. 2. Department of Biomedical Informatics, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Abstract
BACKGROUND: Osteosarcoma (OS) is one of the most common malignant bone tumors. It is essential to explore early diagnostic indicators with high sensitivity and specificity due to the rapid progression and metastasis of OS and the poor survival of metastatic OS patients. However, a few indicators of diagnostic significance have been described. METHODS: A total of 458 OS patients, 312 healthy individuals, and 228 patients with primary benign bone lesions were included. Logistic regression was performed on 46 clinical laboratory parameters to establish the diagnostic classifiers, which were evaluated by analysis of the receiver operating characteristic (ROC) curves. RESULTS: We established three diagnostic classifiers, called Cos for all ages, Clos for low ages, and Chos for high ages, with clinical laboratory parameters to distinguish OS from healthy individuals. All classifiers showed better diagnostic performances than alkaline phosphatase (ALP) in the independent validation cohort. In addition, these classifiers had better ability than ALP to discriminate OS from primary benign bone lesions. Furthermore, Cos , Clos, and Chos had larger AUC than ALP to identify small-size and early-stage OS and could also detect ALP-negative OS effectively. CONCLUSION: Our study suggests the potential of Cos , Clos , and Chos as non-invasive biomarkers for early OS.
BACKGROUND:Osteosarcoma (OS) is one of the most common malignant bone tumors. It is essential to explore early diagnostic indicators with high sensitivity and specificity due to the rapid progression and metastasis of OS and the poor survival of metastatic OS patients. However, a few indicators of diagnostic significance have been described. METHODS: A total of 458 OS patients, 312 healthy individuals, and 228 patients with primary benign bone lesions were included. Logistic regression was performed on 46 clinical laboratory parameters to establish the diagnostic classifiers, which were evaluated by analysis of the receiver operating characteristic (ROC) curves. RESULTS: We established three diagnostic classifiers, called Cos for all ages, Clos for low ages, and Chos for high ages, with clinical laboratory parameters to distinguish OS from healthy individuals. All classifiers showed better diagnostic performances than alkaline phosphatase (ALP) in the independent validation cohort. In addition, these classifiers had better ability than ALP to discriminate OS from primary benign bone lesions. Furthermore, Cos , Clos, and Chos had larger AUC than ALP to identify small-size and early-stage OS and could also detect ALP-negative OS effectively. CONCLUSION: Our study suggests the potential of Cos , Clos , and Chos as non-invasive biomarkers for early OS.
Authors: Jos A M Bramer; Adesegun A Abudu; Roger M Tillman; Simon R Carter; Vaiyapuri P Sumathi; Robert J Grimer Journal: Eur J Cancer Date: 2005-11-07 Impact factor: 9.162
Authors: Philipp T Funovics; Gundula Edelhauser; Martin A Funovics; Christoph Laux; Dominik Berzaczy; Bernd Kubista; Rainer I Kotz; Martin Dominkus Journal: Int Orthop Date: 2011-01-21 Impact factor: 3.075
Authors: Yiting Li; Manjula Nakka; Aaron J Kelly; Ching C Lau; Mark Krailo; Donald A Barkauskas; John M Hicks; Tsz-Kwong Man Journal: Cancer Res Date: 2016-04-19 Impact factor: 12.701
Authors: G Bacci; P Picci; S Ferrari; M Orlandi; P Ruggieri; R Casadei; A Ferraro; R Biagini; A Battistini Journal: Cancer Date: 1993-02-15 Impact factor: 6.860